Related Experiment Video
Updated: Feb 9, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?
11 Centre of Inflammation and Metabolism, Copenhagen, Denmark.
Cancer cachexia, a wasting syndrome, involves muscle loss and reduced function due to poor intake and abnormal metabolism. Understanding its mechanisms, like white adipose tissue browning, is key for better clinical management and screening tools.
Area of Science:
- Oncology
- Metabolism
- Physiology
Background:
- Cancer cachexia is a complex wasting syndrome impacting cancer patients.
- It leads to muscle loss, reduced physical function, and decreased survival.
- Current understanding of its mechanisms remains incomplete for many clinicians.
Purpose of the Study:
- To review current knowledge on cancer cachexia mechanisms.
- To identify clinical management strategies for lung cancer patients.
- To consider variables for a future cancer cachexia screening tool.
Main Methods:
- Review of preclinical and clinical studies on cancer cachexia.
- Analysis of the role of cytokines and metabolic changes.
- Examination of white adipose tissue browning in cancer progression.
Main Results:
- Cancer cachexia involves reduced food intake and abnormal metabolism.
- Cytokines (IL-1α, IL-6, TNFα) and white adipose tissue browning contribute to increased energy expenditure.
- Preclinical data suggests early white adipose tissue browning in cachexia progression.
Conclusions:
- A coherent mechanistic explanation for cancer cachexia is still lacking.
- Clinical management should address food intake, systemic inflammation, and muscle dysfunction.
- Further translational research is needed to develop effective screening tools for clinicians.
More Related Videos
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Related Concept Videos
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Acute Pancreatitis II: Clinical Manifestations and Management